Autor: "Sasano H" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma.
Autorzy:: Lomphithak T; Graduate Program in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Akara-Amornthum P; Graduate Program in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Murakami K; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Hashimoto M; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Usubuchi H; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Iwabuchi E; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Unno M; Department of Surgery, Tohoku University School of Medicine, Sendai, Miyagi, 98-8075, Japan.
Cai Z; Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.
Sasano H; Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Jitkaew S; Age-Related Inflammation and Degeneration Research Unit, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jun 03; Vol. 11 (1), pp. 11743. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor*
B7-H1 Antigen/*genetics
Bile Duct Neoplasms/*etiology
Bile Duct Neoplasms/*pathology
Cholangiocarcinoma/*etiology
Cholangiocarcinoma/*pathology
Necroptosis/*immunology
Bile Duct Neoplasms/mortality ; Cholangiocarcinoma/mortality ; Cytokines/genetics ; Cytokines/metabolism ; Humans ; Kaplan-Meier Estimate ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Models, Biological ; Proportional Hazards Models ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Tumor-Associated Macrophages/immunology ; Tumor-Associated Macrophages/metabolism ; Tumor-Associated Macrophages/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism.
Autorzy:: Sato M; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Harada-Shoji N; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. .
Toyohara T; Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Soga T; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, 997-0035, Japan.
Itoh M; Sendai Medical Imaging Center, 2-1-25 Itsutsubashi, Aoba-ku, Sendai, 980-0022, Japan.
Miyashita M; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Tada H; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Amari M; Department of Breast Surgery, Tohoku Kosai Hospital, 2-3-11 Kokubuncho, Aoba-ku, Sendai, 980-0803, Japan.
Anzai N; Department of Pharmacology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chiba, 260-0856, Japan.
Furumoto S; Cyclotron and Radioisotope Center, Tohoku University School of Medicine, 6-3 Aramaki-aza-Aoba, Aoba-ku, Sendai, 980-8578, Japan.
Abe T; Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Suzuki T; Department of Pathology and Histotechonology, Tohoku University Graduate School of Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Ishida T; Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Sasano H; Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jan 12; Vol. 11 (1), pp. 589. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Gene Expression*
Amino Acids/*metabolism
Breast Neoplasms/*genetics
Breast Neoplasms/*metabolism
Large Neutral Amino Acid-Transporter 1/*physiology
Aged ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/drug therapy ; Cell Proliferation/genetics ; Drug Resistance, Neoplasm/genetics ; Energy Metabolism/genetics ; Female ; Glucose/metabolism ; Humans ; Large Neutral Amino Acid-Transporter 1/genetics ; Large Neutral Amino Acid-Transporter 1/metabolism ; MCF-7 Cells ; Middle Aged ; Neoadjuvant Therapy ; Positron Emission Tomography Computed Tomography